210 related articles for article (PubMed ID: 11513907)
1. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia.
Mawer C; Ignatenko N; Wares D; Strelis A; Golubchikova V; Yanova G; Lyagoshina T; Sharaburova O; Banatvala N
Lancet; 2001 Aug; 358(9280):445-9. PubMed ID: 11513907
[TBL] [Abstract][Full Text] [Related]
2. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of the russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia.
Jacobs B; Clowes C; Wares F; Polivakho V; Lyagoshina T; Peremitin G; Banatvala N
Int J Tuberc Lung Dis; 2002 May; 6(5):396-405. PubMed ID: 12019915
[TBL] [Abstract][Full Text] [Related]
4. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
Kameda K; Kawabata S; Masuda N
Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
[TBL] [Abstract][Full Text] [Related]
5. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.
Seung KJ; Gelmanova IE; Peremitin GG; Golubchikova VT; Pavlova VE; Sirotkina OB; Yanova GV; Strelis AK
Clin Infect Dis; 2004 Nov; 39(9):1321-8. PubMed ID: 15494909
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
7. Implementation of the DOTS strategy for tuberculosis in the Leningrad Region, Russian Federation (1998-1999).
Ruohonen RP; Goloubeva TM; Trnka L; Fomin MM; Zhemkova GA; Sinitsyn AV; Lichachev AA; Koskela KG
Int J Tuberc Lung Dis; 2002 Mar; 6(3):192-7. PubMed ID: 11934136
[TBL] [Abstract][Full Text] [Related]
8. [Ways of overcoming drug resistance in patients with pulmonary tuberculosis].
Grishin MN; Svistov VV; Krivoshein IuS
Probl Tuberk; 2002; (3):16-8. PubMed ID: 12066525
[TBL] [Abstract][Full Text] [Related]
9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
10. [A controlled clinical trial of long course chemotherapy regimens containing rifabutin in the treatment of multi-drug resistant pulmonary tuberculosis].
Zhu LZ; Fu Y; Chu NH; Ye ZZ; Xiao HP; Wang W; Yuan SL; Zhang X; Luo YA; Ma LP
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):520-3. PubMed ID: 17074263
[TBL] [Abstract][Full Text] [Related]
11. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Gupta R; Espinal MA; Raviglione MC
Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
[No Abstract] [Full Text] [Related]
12. Initial drug resistance pattern among pulmonary tuberculosis patients.
Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
[TBL] [Abstract][Full Text] [Related]
13. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
[TBL] [Abstract][Full Text] [Related]
14. [Drug resistance of Mycobacterium tuberculosis in the Sverdlovsk Region].
Nechaeva OB; Skachkova EI; Fomina NI
Probl Tuberk; 2002; (9):8-11. PubMed ID: 12524978
[TBL] [Abstract][Full Text] [Related]
15. [Efficiency of treatment for recurrent tuberculosis and its influencing factors].
Il'ina TIa; Zhangireev AA; Sidorenko OA
Tuberk Biolezni Legkih; 2009; (12):38-42. PubMed ID: 20099386
[TBL] [Abstract][Full Text] [Related]
16. Treatment of multidrug-resistant tuberculosis in Russian prisons.
Lafontaine D; Slavuski A; Vezhnina N; Sheyanenko O
Lancet; 2004 Jan; 363(9404):246-7. PubMed ID: 14738811
[No Abstract] [Full Text] [Related]
17. [Studies on sputum conversion of smear-positive, previously untreated pulmonary tuberculosis: a comparison of short-course and standard chemotherapy regimens].
Huang M
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Feb; 9(1):1-5, 61. PubMed ID: 3743274
[No Abstract] [Full Text] [Related]
18. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
[TBL] [Abstract][Full Text] [Related]
19. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
20. Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required?
Bastian I; Rigouts L; Van Deun A; Portaels F
Bull World Health Organ; 2000; 78(2):238-51. PubMed ID: 10743297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
